NCT03350425View on ClinicalTrials.gov

Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients

CompletedOBSERVATIONAL
Enrollment

792

Participants

Timeline

Start Date

December 21, 2017

Primary Completion Date

December 1, 2022

Study Completion Date

December 31, 2022

Conditions
CKD (Chronic Kidney Disease) Stage 5DPneumonia
Trial Locations (12)

20246

University Hospital Hamburg-Eppendorf, Hamburg

23562

University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck

23845

Medical Clinic, Research Center Borstel, Borstel

30625

Hannover Medical School, Hanover

35043

University Hospital Giessen und Marburg, Marburg site, Marburg

35392

University Hospital Giessen und Marburg, Giessen site, Giessen

50937

University Hospital Cologne, Cologne

53127

University Hospital Bonn, Bonn

69120

University Hospital Heidelberg, Heidelberg

72074

Eberhard Karls University Tübingen, Tübingen

80336

Hospital of the Ludwig-Maximilians-University (LMU), Munich

81675

The University Hospital Klinikum rechts der Isar - MRI TUM, Munich

Sponsors
All Listed Sponsors
collaborator

German Center for Infection Research

OTHER

lead

University of Cologne

OTHER

NCT03350425 - Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients | Biotech Hunter | Biotech Hunter